Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer.
Younes MN, Kim S, Yigitbasi OG, Mandal M, Jasser SA, Dakak Yazici Y, Schiff BA, El-Naggar A, Bekele BN, Mills GB, Myers JN.
Younes MN, et al. Among authors: kim s.
Mol Cancer Ther. 2005 Aug;4(8):1146-56. doi: 10.1158/1535-7163.MCT-05-0078.
Mol Cancer Ther. 2005.
PMID: 16093430